Zenas BioPharma (ZBIO) Net Cash Flow (QoQ) (2024 - 2026)

Zenas BioPharma (ZBIO) Net Cash Flow (QoQ) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Zenas BioPharma 1.72 Bn 1.72 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 8,000.59%
Dec 31, 2025 -106.90%
Sep 30, 2025 146.97%
Jun 30, 2025 -23.60%
Mar 31, 2025 -204.74%
Dec 31, 2024 -122.95%
Sep 30, 2024 20.05%
Jun 30, 2024 843.46%
Mar 31, 2024 -28.59%